Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-10), Bioiasis AD's share price is €8.25. Bioiasis AD's Book Value per Share for the quarter that ended in Sep. 2025 was €0.28. Hence, Bioiasis AD's PB Ratio of today is 29.05.
Good Sign:
Bioiasis AD stock PB Ratio (=29.05) is close to 10-year low of 29.05.
The historical rank and industry rank for Bioiasis AD's PB Ratio or its related term are showing as below:
XBUL:BIOA'
s PB Ratio Range Over the Past 10 Years
Min: 29.05 Med: 70.22 Max: 309.23
Current: 29.05
During the past 13 years, Bioiasis AD's highest PB Ratio was 309.23. The lowest was 29.05. And the median was 70.22.
XBUL:BIOA's PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.135
vs XBUL:BIOA: 29.05
During the past 12 months, Bioiasis AD's average Book Value Per Share Growth Rate was 446.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -4.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -15.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -1.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bioiasis AD was 54.40% per year. The lowest was -36.50% per year. And the median was -3.65% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bioiasis AD PB Ratio Related Terms
Bioiasis AD PB Ratio Historical Data
* Premium members only.
The historical data trend for Bioiasis AD's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bioiasis AD's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioiasis AD PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioiasis AD's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bioiasis AD's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Bioiasis AD's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bioiasis AD (XBUL:BIOA) has a PB Ratio of 29.05 as of Sep. 10, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bioiasis AD and its competitors. This is 59% below median its historical median of 70.22. Over the past decade, Bioiasis AD's PB Ratio has ranged from 29.05 to 309.23.
Is Bioiasis AD's PB Ratio too high?
Bioiasis AD's current PB Ratio of 29.05 is 59% below median its 10-year median of 70.22. Over the past 10 years, this metric has ranged from a low of 29.05 to a high of 309.23. The Medical Devices & Instruments industry median PB Ratio is 2.14. Bioiasis AD's value of 29.05 is 1260.7% above this industry median. Overall, Bioiasis AD has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioiasis AD's PB Ratio compare to ABT and SYK?
Bioiasis AD's PB Ratio of 29.05 can be compared against companies in the Medical Devices & Instruments industry. The industry median PB Ratio is 2.14. Bioiasis AD's value of 29.05 is 1260.7% above this benchmark. Historically, Bioiasis AD's own PB Ratio has ranged from 29.05 to 309.23 over the past decade. While the company's 10-year median is 70.22 vs. the industry median of 2.14, Bioiasis AD has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.14, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioiasis AD's current PB Ratio of 29.05 is 1260.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bioiasis AD and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioiasis AD's current PB Ratio is 29.05, which is 59% below median its own 10-year median of 70.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioiasis AD stock overvalued right now?
Bioiasis AD (XBUL:BIOA) has a current PB Ratio of 29.05. The current PB Ratio is 29.05, which is 59% below median its 10-year median of 70.22 and 1260.7% above the Medical Devices & Instruments industry median of 2.14. Bioiasis AD's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bioiasis AD (XBUL:BIOA), the current PB Ratio is 29.05 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
12GF Score
Get the complete analysis for XBUL:BIOA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:BIOA has been successfully added to your 
